BEIJING, May 6, 2025 /PRNewswire/ -- Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class analgesic drug (research code: TRD205), a highly selective angiotensin II type 2 receptor (AT2R) antagonist, with the first patient successfully dosed. As the first...
SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- The Sunhak Peace Prize Committee, chaired by José Manuel Barroso, former President of the European Commission, proudly...
LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- BLUETTI, a trailblazer in clean energy technology, unveiled three new product series—Apex, Elite, and EnergyPro—during its Breaking the...
Celebrating exceptional leadership in the global supply chain industry
SINGAPORE, Jan. 15, 2025 /PRNewswire/ -- Alcott Global proudly announces the launch of the 2025 edition...
LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- A new smart birdfeeder from HIXXHOME and its companion app from CoolFly have been recognized by Home Digest...